"What is tirzepatide and how do Zepbound and Mounjaro differ?"
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Zepbound (FDA-approved Dec 2023 for weight loss) and Mounjaro (for type 2 diabetes). SURMOUNT trials showed up to 22.5% body weight reduction over 72 weeks with 2,539 participants. Available through Youth and Soul from $135/mo. Start your assessment | Compare GLP-1s. Sources: FDA, NEJM
Compare side effects of semaglutide, tirzepatide, and liraglutide.
GLP-1 medication costs and insurance coverage guide for 2026.
Compare oral vs injectable semaglutide forms.
Compare compounded semaglutide to brand-name Ozempic and Wegovy. Learn about FDA regulations, safety, cost savings, and how to get it through licensed telehealth.
Expert guide to semaglutide - Wegovy and Ozempic explained with clinical data.
Expert guide to liraglutide and Saxenda for weight loss.